Lupin divests US commercial women's health specialty business to Evofem
Lupin can receive a potential total consideration of up to USD 84 million based on future contingent milestones
Lupin can receive a potential total consideration of up to USD 84 million based on future contingent milestones
Vonoprazan is a potassium-competitive acid blocker (P-CAB) used for the treatment of acid-related disorders
Shoff brings over 30 years of international experience in in vitro diagnostics, healthcare distribution and veterinary diagnostics
€ 6.6 million investment at Nantong site expands production capabilities for cell culture media
Findings from the SEIMC-GeSIDA Foundation (FSG) PASO-DOBLE study will include treatment efficacy, safety, and weight gain
The company will address these observations within the stipulated timeline
The company is planning to expand its plant capacity in in Vapi
Directs officials to ensure that challenges hampering their effective implementation are resolved early in coordination with states
KIMS already have a multi-specialty hospital and gastro unit at Vizag
Subscribe To Our Newsletter & Stay Updated